SUI is one of the few altcoins resilient to recent downturns, holding steady for the week with a 0.5% gain—making its claim ...

XRP currently trades around $2.05 with analysts predicting a potential rise to $5-$27 in the coming months based on technical ...

Shiba Inu holds the largest market capitalization among all the memecoins, but we now see more enhanced memecoins offering ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade ...

XRP gains clarity, TON leads growth, ADA stumbles, and CRO surprises with an ETF twist. Here’s what’s driving the crypto ...

Analysts' ratings for Alnylam Pharmaceuticals ALNY over the last quarter vary from bullish to bearish, as provided by 27 ...

EnerSys, a leading U.S. industrial battery maker, benefits from electrification, automation & data center growth, ensuring ...

The emerging "Agentic AI Era" offers a transformative opportunity for small and medium businesses to address longstanding ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

Currently, India imposes a 10 per cent tariff on pharmaceutical imports from the US, while the US does not levy any tariff on ...